Mimetogen Pharmaceuticals

Peptidomimetics as a novel approach to treating ophthalmic diseases

placeMontreal, Montreal, Canada calendar_todayFounded 2004 groups3 employees language mimetogen.com

Innovation

4 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 400 times.

YearFilings
20122
20132
20142
20152
20162
20173
20182
20192
20202
20212
20231
20251

Investor mix

4 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital250%
Private equity125%
Other / undisclosed125%
Coming soon